Blueprint Medicines Corp (BPMC) — Long-term Investment Intensity
Blueprint Medicines Corp (BPMC) has a Long-term Investment Intensity of 27.1% as of March 2025. Long-term investments of $323.55 Million represent 27.1% of total assets of $1.20 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BPMC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Blueprint Medicines Corp Long-term Investment Intensity (2014–2024)
This chart shows how Blueprint Medicines Corp's Long-term Investment Intensity has evolved across 8 annual periods from 2014 to 2024. As of March 2025, the intensity stands at 27.1%, reflecting long-term investments of $323.55 Million against total assets of $1.20 Billion USD. Explore BPMC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Blueprint Medicines Corp (2014–2024)
The table below presents the year-by-year Long-term Investment Intensity for Blueprint Medicines Corp from 2014 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Blueprint Medicines Corp (BPMC) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 23.5% | $277.15 Million | $1.18 Billion | ▲ +15.5 pp |
| 2023 | 8.0% | $84.32 Million | $1.05 Billion | ▼ -1.9 pp |
| 2022 | 9.9% | $133.48 Million | $1.35 Billion | ▼ -34.6 pp |
| 2021 | 44.5% | $557.53 Million | $1.25 Billion | ▲ +5.1 pp |
| 2020 | 39.4% | $677.87 Million | $1.72 Billion | ▲ +30.3 pp |
| 2019 | 9.1% | $64.41 Million | $707.69 Million | ▼ -10.0 pp |
| 2016 | 19.1% | $54.06 Million | $282.80 Million | ▼ -89.2 pp |
| 2014 | 108.3% | $54.06 Million | $49.92 Million | — |